Long-term Efficacy of Safinamide on Parkinson’s Disease Chronic Pain

INTRODUCTION: Chronic pain is an important yet overlooked non-motor symptom of Parkinson’s disease (PD), caused by an imbalance of the dopaminergic and glutamatergic systems. Safinamide has a multimodal mechanism of action, dopaminergic (reversible MAO-B inhibition) and non-dopaminergic (modulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattaneo, Carlo, Kulisevsky, Jaime, Tubazio, Viviana, Castellani, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910467/
https://www.ncbi.nlm.nih.gov/pubmed/29542008
http://dx.doi.org/10.1007/s12325-018-0687-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910467/
https://www.ncbi.nlm.nih.gov/pubmed/29542008
http://dx.doi.org/10.1007/s12325-018-0687-z

Ejemplares similares